Advances in Biomarkers and Techniques for Pancreatic Cancer Diagnosis

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2022 Jun 27

PMID 35761336

Authors

Haotian Wu

Suwen Ou

Hongli Zhang

Rui Huang

Shan Yu

Ming Zhao

Sheng Tai

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer is the most lethal type of malignancy and is characterized by high invasiveness without severe symptoms. It is difficult to detect PC at an early stage because of the low diagnostic accuracy of existing routine methods, such as abdominal ultrasound, CT, MRI, and endoscopic ultrasound (EUS). Therefore, it is of value to develop new diagnostic techniques for early detection with high accuracy. In this review, we aim to highlight research progress on novel biomarkers, artificial intelligence, and nanomaterial applications on the diagnostic accuracy of pancreatic cancer.

Citing Articles

PRIM2 promotes proliferation and metastasis of pancreatic ductal adenocarcinoma through interactions with FAM111B.

Yin J, Qin F, Chen H, Wang X, Xia R, Ni B Med Oncol. 2024; 42(1):6.

PMID: 39556158 DOI: 10.1007/s12032-024-02554-8.

Oligoribonucleotide interference-PCR-based methods for the sensitive and accurate detection of mutations.

Fujita H, Fujita T, Ishido K, Hakamada K, Fujii H Biol Methods Protoc. 2024; 9(1):bpae071.

PMID: 39478810 PMC: 11522869. DOI: 10.1093/biomethods/bpae071.

Highly sensitive multiplexed colorimetric lateral flow immunoassay by plasmon-controlled metal-silica isoform nanocomposites: PINs.

Shin M, Kim W, Yoo K, Cho H, Jang S, Bae H Nano Converg. 2024; 11(1):42.

PMID: 39446245 PMC: 11502615. DOI: 10.1186/s40580-024-00449-y.

The road to overcome pancreatic cancer: Where are we?.

Tirpe A, Streianu C, Isachesku E, Simon I, Berindan-Neagoe I Heliyon. 2024; 10(19):e38196.

PMID: 39403527 PMC: 11471497. DOI: 10.1016/j.heliyon.2024.e38196.

Unraveling the role of Major Vault Protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma.

Wu X, Hao L, Lin J, Guo X, Luo Y, Li C Front Immunol. 2024; 15:1399222.

PMID: 39026679 PMC: 11254802. DOI: 10.3389/fimmu.2024.1399222.

References

Fattahi R, Balci N, Perman W, Hsueh E, AlKaade S, Havlioglu N . Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging. 2009; 29(2):350-6. DOI: 10.1002/jmri.21651. View

Yi J, Guzzetta A, Bailey V, Downing S, Van Neste L, Chiappinelli K . Novel methylation biomarker panel for the early detection of pancreatic cancer. Clin Cancer Res. 2013; 19(23):6544-6555. PMC: 4310572. DOI: 10.1158/1078-0432.CCR-12-3224. View

Yang J, Sun Y, Liu D, Zhang J, Li J, Hua R . MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Am J Cancer Res. 2014; 4(6):663-73. PMC: 4266702. View

Li L, Zhang G, Chen H, Zhao Z, Chen H, Liu H . Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer. Oncotarget. 2016; 7(44):71773-71781. PMC: 5342121. DOI: 10.18632/oncotarget.12365. View

Das A, Nguyen C, Li F, Li B . Digital image analysis of EUS images accurately differentiates pancreatic cancer from chronic pancreatitis and normal tissue. Gastrointest Endosc. 2008; 67(6):861-7. DOI: 10.1016/j.gie.2007.08.036. View

Momeni-Boroujeni A, Yousefi E, Somma J . Computer-assisted cytologic diagnosis in pancreatic FNA: An application of neural networks to image analysis. Cancer Cytopathol. 2017; 125(12):926-933. DOI: 10.1002/cncy.21915. View

Kumar R, Roy I, Ohulchanskyy T, Goswami L, Bonoiu A, Bergey E . Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano. 2009; 2(3):449-56. DOI: 10.1021/nn700370b. View

Le M, Chen J, Wang L, Wang Z, Liu W, Cheng K . Automated diagnosis of prostate cancer in multi-parametric MRI based on multimodal convolutional neural networks. Phys Med Biol. 2017; 62(16):6497-6514. DOI: 10.1088/1361-6560/aa7731. View

Sun L, Burnett J, Guo C, Xie Y, Pan J, Yang Z . CPA4 is a promising diagnostic serum biomarker for pancreatic cancer. Am J Cancer Res. 2016; 6(1):91-6. PMC: 4759400. View

10.

Zou X, Wei J, Huang Z, Zhou X, Lu Z, Zhu W . Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Cancer Med. 2019; 8(6):2810-2822. PMC: 6558458. DOI: 10.1002/cam4.2145. View

11.

Kisiel J, Raimondo M, Taylor W, Yab T, Mahoney D, Sun Z . New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice. Clin Cancer Res. 2015; 21(19):4473-81. PMC: 4592385. DOI: 10.1158/1078-0432.CCR-14-2469. View

12.

Konno M, Koseki J, Asai A, Yamagata A, Shimamura T, Motooka D . Distinct methylation levels of mature microRNAs in gastrointestinal cancers. Nat Commun. 2019; 10(1):3888. PMC: 6715669. DOI: 10.1038/s41467-019-11826-1. View

13.

Chassagnon G, Vakalopoulou M, Paragios N, Revel M . Artificial intelligence applications for thoracic imaging. Eur J Radiol. 2019; 123:108774. DOI: 10.1016/j.ejrad.2019.108774. View

14.

Henriksen S, Madsen P, Larsen A, Johansen M, Pedersen I, Krarup H . Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma. Oncotarget. 2017; 8(55):93942-93956. PMC: 5706846. DOI: 10.18632/oncotarget.21397. View

15.

Yang F, Liu D, Guo J, Ge N, Zhu P, Liu X . Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol. 2018; 23(47):8345-8354. PMC: 5743505. DOI: 10.3748/wjg.v23.i47.8345. View

16.

Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H . Nanoparticles for cancer imaging: The good, the bad, and the promise. Nano Today. 2014; 8(5):454-460. PMC: 4240321. DOI: 10.1016/j.nantod.2013.06.001. View

17.

Rosenberger I, Strauss A, Dobiasch S, Weis C, Szanyi S, Gil-Iceta L . Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer. J Control Release. 2015; 214:76-84. DOI: 10.1016/j.jconrel.2015.07.017. View

18.

Pelaz B, Alexiou C, Alvarez-Puebla R, Alves F, Andrews A, Ashraf S . Diverse Applications of Nanomedicine. ACS Nano. 2017; 11(3):2313-2381. PMC: 5371978. DOI: 10.1021/acsnano.6b06040. View

19.

Walczak S, Velanovich V . An Evaluation of Artificial Neural Networks in Predicting Pancreatic Cancer Survival. J Gastrointest Surg. 2017; 21(10):1606-1612. DOI: 10.1007/s11605-017-3518-7. View

20.

Liu S, Li S, Guo Y, Zhou Y, Zhang Z, Li S . Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network. Chin Med J (Engl). 2019; 132(23):2795-2803. PMC: 6940082. DOI: 10.1097/CM9.0000000000000544. View